Literature DB >> 7705927

Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis.

M Llovera1, C Garcia-Martinez, N Agell, F J Lopez-Soriano, J M Argiles.   

Abstract

Rats bearing the Yoshida AH-130 ascites hepatoma for 7 days showed an important decrease in muscle mass--over 30% in gastrocnemius and extensor digitorum longus (EDL)--in relation to non-tumour-bearing controls, which is associated with an increased proteolytic rate in in vitro incubation. In order to identify the precise biochemical process which was involved, we measured different proteolytic systems in incubated EDL muscles. The capacity for intralysosomal proteolysis, as measured by sensitivity to methylamine, was not increased in tumour-bearing rats, suggesting that the mechanism involved in the increased proteolytic rate was extralysosomal. Incubations using the Ca2+ ionophore A23187 revealed no change in the activity of calcium-dependent proteases as a consequence of tumour growth. Finally, muscle incubation in an ATP-depleted medium allowed us to conclude that energy-dependent proteases were involved in the activation of muscle proteolysis in tumour-bearing rats. In particular, the ubiquitin-dependent proteolytic system is involved, since there is an important increase in ubiquitin conjugates in the skeletal muscle of tumour-bearing rats. It may thus be suggested that extralysosomal ATP- and ubiquitin-dependent proteases underlie the biochemical mechanism of muscle wastage associated with cancer cachexia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705927     DOI: 10.1002/ijc.2910610123

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

Review 1.  Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks.

Authors:  Simon S Wing; Stewart H Lecker; R Thomas Jagoe
Journal:  Crit Rev Clin Lab Sci       Date:  2011-06-24       Impact factor: 6.250

Review 2.  Autophagic proteolysis: control and specificity.

Authors:  E F Blommaart; J J Luiken; A J Meijer
Journal:  Histochem J       Date:  1997-05

Review 3.  The "parallel pathway": a novel nutritional and metabolic approach to cancer patients.

Authors:  Maurizio Muscaritoli; Alessio Molfino; Gianfranco Gioia; Alessandro Laviano; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2010-07-02       Impact factor: 3.397

Review 4.  Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.

Authors:  D Attaix; L Combaret; T Tilignac; D Taillandier
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

Review 5.  Muscle alterations in the development and progression of cancer-induced muscle atrophy: a review.

Authors:  Megan E Rosa-Caldwell; Dennis K Fix; Tyrone A Washington; Nicholas P Greene
Journal:  J Appl Physiol (1985)       Date:  2019-11-14

6.  Increased muscle proteasome activity correlates with disease severity in gastric cancer patients.

Authors:  Maurizio Bossola; Maurizio Muscaritoli; Paola Costelli; Gabriella Grieco; Gabriella Bonelli; Fabio Pacelli; Filippo Rossi Fanelli; Giovanni Battista Doglietto; Francesco Maria Baccino
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

7.  The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis.

Authors:  Samuel Hammond; Simon Erridge; Nagina Mangal; Barbara Pacchetti; Mikael H Sodergren
Journal:  Cannabis Cannabinoid Res       Date:  2021-10-18

8.  A sarcoma-derived protein regulates hepatocyte metabolism via autocrine production of tumor necrosis factor-alpha.

Authors:  C P Fischer; B P Bode; W W Souba
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

9.  Formoterol treatment downregulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats.

Authors:  Sílvia Busquets; Míriam Toledo; Enrica Marmonti; Marcel Orpí; Eva Capdevila; Angelica Betancourt; Francisco J López-Soriano; Josep M Argilés
Journal:  Oncol Lett       Date:  2011-10-13       Impact factor: 2.967

10.  Protein and Amino Acid Supplementation Does Not Alter Proteolytic Gene Expression following Immobilization.

Authors:  Jennifer A Bunn; Thomas W Buford; Monica C Serra; Richard B Kreider; Darryn S Willoughby
Journal:  J Nutr Metab       Date:  2011-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.